| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -39,885 | -26,420 |
| Depreciation and amortization expense | 1,050 | 659 |
| Non-cash lease expense | 76 | 50 |
| Stock-based compensation expense | 8,864 | 5,515 |
| Amortization of debt discount and accretion of premium on term loans | 308 | 202 |
| Accretion (amortization) of discount and premium on marketable securities | 1,389 | 487 |
| Change in fair value of warrant liability | 0 | 0 |
| Loss on disposal of property and equipment and recorders | -79 | -50 |
| Accounts receivable, net | 1,356 | 1,434 |
| Inventory | -913 | -937 |
| Prepaid expenses and other current assets | -391 | -1,229 |
| Contract costs | 627 | 351 |
| Other non-current assets | 221 | 226 |
| Accounts payable | 1,156 | 1,361 |
| Accrued liabilities and other current liabilities | 748 | -17 |
| Contract liabilities | 11 | 96 |
| Net cash used in operating activities | -30,034 | -18,936 |
| Purchases of recorders and related components | 382 | 288 |
| Purchases of property and equipment | 588 | 219 |
| Purchases of marketable securities | 188,775 | 142,794 |
| Proceeds from maturities of marketable securities | 45,500 | 6,000 |
| Net cash used in investing activities | -144,245 | -137,301 |
| Proceeds related to employee stock plans | 3,798 | - |
| Proceeds from debt issuance | 0 | 0 |
| Debt issuance cost | 150 | 150 |
| Payment of deferred ipo offering costs | 0 | 0 |
| Proceeds from exercise of common stock pursuant to stock option exercises | - | 2,158 |
| Net cash provided by financing activities | 3,648 | 2,008 |
| Net decrease in cash and cash equivalents | -170,631 | -154,229 |
| Cash and cash equivalents at beginning of period | 194,370 | - |
| Cash and cash equivalents at end of period | 23,739 | - |
Ceribell, Inc. (CBLL)
Ceribell, Inc. (CBLL)